Published in Clin Chem Lab Med on November 01, 2001
Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). J Nutr (2015) 1.20
Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markers. Tex Heart Inst J (2005) 0.86
Neighborhoods and systemic inflammation: high CRP among legal and unauthorized Brazilian migrants. Health Place (2012) 0.81
Combined oral contraception and obesity are strong predictors of low-grade inflammation in healthy individuals: results from the Danish Blood Donor Study (DBDS). PLoS One (2014) 0.80
A high sensitivity assay is more accurate than a classical assay for the measurement of plasma CRP levels in endometriosis. Reprod Biol Endocrinol (2011) 0.75
Detection of C-reactive protein on an integrated microfluidic system by utilizing field-effect transistors and aptamers. Biomicrofluidics (2017) 0.75
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA (2001) 15.85
Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation (2000) 8.17
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med (2001) 7.51
Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr (2001) 5.67
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA (2001) 5.54
Long-term effects of pravastatin on plasma concentration of C-reactive protein. The Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1999) 3.90
Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation (2000) 3.66
Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators. Circulation (1998) 3.19
Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem (2001) 3.17
Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults. Clin Chem (2001) 3.12
Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays. Clin Chem (2001) 2.81
Blood pressure and inflammation in apparently healthy men. Hypertension (2001) 2.55
Predictive value of cardiac troponin T in pediatric patients at risk for myocardial injury. Circulation (1997) 2.34
Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease. J Clin Invest (1996) 2.31
Absence of diurnal variation of C-reactive protein concentrations in healthy human subjects. Clin Chem (2001) 2.01
Hormone replacement therapy and increased plasma concentration of C-reactive protein. Circulation (1999) 1.96
C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol (1998) 1.96
The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Kidney Int (2006) 1.84
Plasma sex steroid hormones and risk of developing type 2 diabetes in women: a prospective study. Diabetologia (2007) 1.80
Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem (2000) 1.74
Soluble P-selectin and the risk of future cardiovascular events. Circulation (2001) 1.69
False increase of cardiac troponin I with heterophilic antibodies. Clin Chem (1998) 1.63
Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care (2001) 1.63
Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening. J Am Coll Cardiol (2000) 1.62
Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nat Genet (1999) 1.61
Clinical efficacy of three assays for cardiac troponin I for risk stratification in acute coronary syndromes: a Thrombolysis In Myocardial Infarction (TIMI) 11B Substudy. Clin Chem (2000) 1.58
Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a). Clin Chem (2000) 1.52
Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia. Circulation (2001) 1.50
Inflammation, the acute phase response and atherosclerosis. Clin Chem Lab Med (1999) 1.47
Analytical evaluation of particle-enhanced immunonephelometric assays for C-reactive protein, serum amyloid A and mannose-binding protein in human serum. Ann Clin Biochem (1998) 1.43
Evaluation of the APEC analyzer for whole blood glucose. Testing in a pediatric setting. Am J Clin Pathol (1995) 1.39
Effects of growth hormone administration on inflammatory and other cardiovascular risk markers in men with growth hormone deficiency. A randomized, controlled clinical trial. Ann Intern Med (2000) 1.33
Circulating cell adhesion molecules are correlated with ultrasound-based assessment of carotid atherosclerosis. Arterioscler Thromb Vasc Biol (1998) 1.32
Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk. J Clin Endocrinol Metab (2004) 1.31
Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin. J Clin Oncol (1999) 1.22
Oral administration of clotrimazole and blockade of human erythrocyte Ca(++)-activated K+ channel: the imidazole ring is not required for inhibitory activity. J Pharmacol Exp Ther (1995) 1.17
Effect of vitamin supplementation to HIV-infected pregnant women on the micronutrient status of their infants. Eur J Clin Nutr (2005) 1.12
Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children? J Clin Microbiol (1990) 1.11
Plasma insulin, leptin, and soluble TNF receptors levels in relation to obesity-related atherogenic and thrombogenic cardiovascular disease risk factors among men. Atherosclerosis (2001) 1.11
Glycosylated hemoglobin and risk of colorectal cancer and adenoma (United States). Cancer Causes Control (1999) 1.08
Pediatric reference ranges on the Abbott IMx for FSH, LH, prolactin, TSH, T4, T3, free T4, free T3, T-uptake, IgE, and ferritin. Clin Biochem (1995) 1.07
Moderate alcohol intake and markers of inflammation and endothelial dysfunction among diabetic men. Diabetologia (2004) 1.07
Plasma concentrations of interleukin-6 and abdominal aortic diameter among subjects without aortic dilatation. Arterioscler Thromb Vasc Biol (1999) 1.06
Sciatic nerve blockade in infant, adolescent, and adult rats: a comparison of ropivacaine with bupivacaine. Anesthesiology (1998) 1.06
Dietary and lifestyle factors in relation to plasma leptin concentrations among normal weight and overweight men. Int J Obes Relat Metab Disord (2001) 1.06
Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum. Clin Chem (1986) 1.05
Glycemic status and soluble tumor necrosis factor receptor levels in relation to plasma leptin concentrations among normal weight and overweight US men. Int J Obes Relat Metab Disord (2000) 1.05
Asparaginase-associated lipid abnormalities in children with acute lymphoblastic leukemia. Blood (1997) 1.05
Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation. Clin Chem (2000) 1.04
Docosahexaenoic acid restores endothelial function in children with hyperlipidemia: results from the EARLY study. Int J Clin Pharmacol Ther (2004) 1.01
Direct measurement of LDL-C in children: performance of two surfactant-based methods in a general pediatric population. Clin Biochem (2000) 0.99
Plasma leptin concentrations and four-year weight gain among US men. Int J Obes Relat Metab Disord (2001) 0.98
Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol (2000) 0.98
Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol (2000) 0.98
Analytical performance and clinical efficacy of three routine procedures for LDL cholesterol measurement compared with the ultracentrifugation-dextran sulfate-Mg(2+) method. Clin Chim Acta (2000) 0.98
Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr (1998) 0.97
Role of free radicals in cancer and atherosclerosis. Clin Lab Med (1993) 0.97
A prospective study of lipoprotein(a) and risk of coronary heart disease among women with type 2 diabetes. Diabetologia (2005) 0.95
Cardiac toxicity of intravenous terbutaline for the treatment of severe asthma in children: a prospective assessment. J Pediatr (2000) 0.95
Tandem mass spectrometry method for the quantification of serum busulfan. Ther Drug Monit (2005) 0.95
Hyperlipemic response of young trained and untrained men after a high fat meal. Arteriosclerosis (1989) 0.93
Protracted anemia associated with chronic, relapsing systemic inflammation induced by arthropathic peptidoglycan-polysaccharide polymers in rats. Infect Immun (1989) 0.92
Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Diabetologia (2004) 0.92
High-sensitivity C-reactive protein and atherosclerosis: from theory to therapy. Clin Biochem (2000) 0.91
Hyperproinsulinaemia and risk of Type 2 diabetes mellitus in women. Diabet Med (2005) 0.91
Selenium levels in relation to morbidity and mortality among children born to HIV-infected mothers. Eur J Clin Nutr (2005) 0.90
The use of serum levels of cardiac troponin T to compare the protective activity of dexrazoxane against doxorubicin- and mitoxantrone-induced cardiotoxicity. Cancer Chemother Pharmacol (2001) 0.90
Early high dose antioxidant vitamins do not prevent bronchopulmonary dysplasia in premature baboons exposed to prolonged hyperoxia: a pilot study. Pediatr Res (1998) 0.90
Cross-sectional relations of serum aldosterone and urine sodium excretion to urinary albumin excretion in a community-based sample. Kidney Int (2006) 0.89
Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity. Cancer Res (1998) 0.89
High-sensitivity C-reactive protein, adiposity, and blood pressure in the Yakut of Siberia. Am J Hum Biol (2006) 0.89
International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Standardization Project for the Measurement of Lipoprotein(a). Phase 2: selection and properties of a proposed secondary reference material for lipoprotein(a). Clin Chem Lab Med (1999) 0.88
Blood lead and hemoglobin levels in Andean children with chronic lead intoxication. Neurotoxicology (2000) 0.88
A new therapeutic approach for sickle cell disease. Blockade of the red cell Ca(2+)-activated K+ channel by clotrimazole. Ann N Y Acad Sci (1995) 0.87
Evaluation and clinical application of a direct low-density lipoprotein cholesterol assay in normolipidemic and hyperlipidemic adults. Am J Cardiol (1997) 0.86
Time to positivity of a rapid bedside assay for cardiac-specific troponin T predicts prognosis in acute coronary syndromes: a Thrombolysis in Myocardial Infarction (TIMI) 11A substudy. J Am Coll Cardiol (1998) 0.85
Effects of exercise training on cardiovascular function and plasma lipid, lipoprotein, and apolipoprotein concentrations in premenopausal and postmenopausal women. Arterioscler Thromb (1991) 0.85
Serum lipids, neuroendocrine, and cardiovascular responses to stress in men and women with mild hypertension. Behav Med (1994) 0.85
Effects of a single bout of ultraendurance exercise on lipid levels and susceptibility of lipids to peroxidation in triathletes. JAMA (1996) 0.84
Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. J Heart Lung Transplant (2000) 0.84
Lipoproteins and apolipoproteins. Composition, metabolism, and association with coronary heart disease. Arch Pathol Lab Med (1986) 0.84
Effects of testosterone therapy on cardiovascular risk markers in androgen-deficient women with hypopituitarism. J Clin Endocrinol Metab (2007) 0.83
Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. J Clin Endocrinol Metab (2001) 0.83
A new liquid homogeneous assay for HDL cholesterol determination evaluated in seven laboratories in Europe and the United States. Clin Chem Lab Med (2000) 0.82
Plasma levels of cystatin-C and mannose binding protein are not associated with risk of developing systemic atherosclerosis. Vasc Med (2001) 0.82
Utility of direct measurement of low-density lipoprotein cholesterol in dyslipidemic pediatric patients. Arch Pediatr Adolesc Med (1998) 0.82
Plasma lipids and other cardiovascular risk factors in Costa Rican adolescents. Rev Panam Salud Publica (2000) 0.81
Differential effects of E and droloxifene on C-reactive protein and other markers of inflammation in healthy postmenopausal women. J Clin Endocrinol Metab (2001) 0.81
Changes in cerebrospinal fluid IgG and apolipoprotein E indices in patients with multiple sclerosis during demyelination and remyelination. Clin Chem (1987) 0.81
Efficacy of felbamate in therapy for partial epilepsy in children. J Pediatr (1994) 0.80
Urinary N-acetyl-beta-glucosaminidase and beta-2-microglobulin in the diagnosis of urinary tract infection in febrile infants. Pediatr Infect Dis J (1994) 0.80
Immunoturbidimetric techniques for quantifying apolipoproteins CII and CIII. Clin Chem (1986) 0.80
The effect of low-dose hydrochlorothiazide on blood pressure, serum potassium, and lipoproteins. Pharmacotherapy (1986) 0.79
Gender differences in exercise-induced changes in sex hormone levels and lipid peroxidation in athletes participating in the Hawaii Ironman triathlon. Ginsburg-gender and exercise-induced lipid peroxidation. Clin Chim Acta (2001) 0.79
Effective control of hypercholesterolemia in children with dietary interventions based in pediatric practice. Prev Med (1993) 0.79
Analytical performance and clinical utility of a direct LDL-cholesterol assay in a hyperlipidemic pediatric population. Clin Chem (1996) 0.79